Published in J Immunol on January 15, 2008
Membrane vesicles as conveyors of immune responses. Nat Rev Immunol (2009) 14.72
Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol (2011) 6.96
Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 4.35
Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci (2010) 3.35
Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 3.02
Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev (2012) 2.22
Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. J Clin Invest (2009) 2.10
Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin Immunopathol (2011) 1.93
Antibacterial effect of microvesicles released from human neutrophilic granulocytes. Blood (2012) 1.76
Transfer of extracellular vesicles during immune cell-cell interactions. Immunol Rev (2013) 1.25
Neutrophils in innate and adaptive immunity. Semin Immunopathol (2013) 1.23
Ectosomes as modulators of inflammation and immunity. Clin Exp Immunol (2010) 1.19
Ectosomes released by polymorphonuclear neutrophils induce a MerTK-dependent anti-inflammatory pathway in macrophages. J Biol Chem (2010) 1.19
Neutrophil-derived CCL3 is essential for the rapid recruitment of dendritic cells to the site of Leishmania major inoculation in resistant mice. PLoS Pathog (2010) 1.14
Streptolysin O clearance through sequestration into blebs that bud passively from the plasma membrane. J Cell Sci (2011) 1.11
The immune functions of phosphatidylserine in membranes of dying cells and microvesicles. Semin Immunopathol (2010) 1.03
P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways. Purinergic Signal (2009) 1.02
Antimicrobial peptides: modes of mechanism, modulation of defense responses. Plant Signal Behav (2011) 0.97
Innate immune responses during respiratory tract infection with a bacterial pathogen induce allergic airway sensitization. J Allergy Clin Immunol (2008) 0.96
Immunomodulatory role of microRNAs transferred by extracellular vesicles. Biol Cell (2015) 0.94
Overview of extracellular microvesicles in drug metabolism. Expert Opin Drug Metab Toxicol (2010) 0.91
Neutrophils exert a suppressive effect on Th1 responses to intracellular pathogen Brucella abortus. PLoS Pathog (2013) 0.86
Neutrophil derived microvesicles: emerging role of a key mediator to the immune response. Endocr Metab Immune Disord Drug Targets (2014) 0.86
Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol. Sci Rep (2015) 0.85
Neutrophil-derived JAML inhibits repair of intestinal epithelial injury during acute inflammation. Mucosal Immunol (2014) 0.84
Cell-cell communication via extracellular membrane vesicles and its role in the immune response. Mol Cells (2013) 0.84
Coordinate stimulation of macrophages by microparticles and TLR ligands induces foam cell formation. J Immunol (2012) 0.83
Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasome. Ann Rheum Dis (2015) 0.83
Ectosomes as immunomodulators. Semin Immunopathol (2010) 0.82
Changing world of neutrophils. Pflugers Arch (2013) 0.81
Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther (2016) 0.80
Extracellular Vesicles in Physiology, Pathology, and Therapy of the Immune and Central Nervous System, with Focus on Extracellular Vesicles Derived from Mesenchymal Stem Cells as Therapeutic Tools. Front Cell Neurosci (2016) 0.80
Mechanisms underlying mouse TNF-α stimulated neutrophil derived microparticle generation. Biochem Biophys Res Commun (2013) 0.79
Polymorphonuclear leukocyte inhibition of monocytes/macrophages in the foreign body reaction. J Biomed Mater Res A (2010) 0.78
Circulating membrane-derived microvesicles in redox biology. Free Radic Biol Med (2014) 0.78
Exosomes as the source of biomarkers of metabolic diseases. Ann Pediatr Endocrinol Metab (2016) 0.76
The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression. PLoS One (2015) 0.76
MicroRNA and extracellular vesicles in glioblastoma: small but powerful. Brain Tumor Pathol (2016) 0.76
Extracellular vesicles as mediators of vascular inflammation in kidney disease. World J Nephrol (2016) 0.75
Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis. Arthritis Res Ther (2017) 0.75
Extracellular Vesicles as a Source of Urological Biomarkers: Lessons Learned From Advances and Challenges in Clinical Applications to Major Diseases. Int Neurourol J (2017) 0.75
Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog (2012) 3.35
Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat Immunol (2013) 2.30
What is the role of autoimmunity in type 1 diabetes? A clinical perspective. Diabetologia (2014) 1.80
CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol (2003) 1.76
Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood (2004) 1.72
Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res (2003) 1.47
Emission of membrane vesicles: roles in complement resistance, immunity and cancer. Springer Semin Immunopathol (2005) 1.39
HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts. PLoS Med (2007) 1.20
Ectosomes released by polymorphonuclear neutrophils induce a MerTK-dependent anti-inflammatory pathway in macrophages. J Biol Chem (2010) 1.19
Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients. Ann Neurol (2011) 1.15
Complement mediates the binding of HIV to erythrocytes. J Immunol (2004) 1.05
Atypical hemolytic uremic syndrome: update on the complement system and what is new. Nephron Clin Pract (2010) 1.04
Erythrocyte-derived ectosomes have immunosuppressive properties. J Leukoc Biol (2008) 1.01
The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans. Blood (2005) 1.01
Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis (2010) 0.96
Microparticles released by human neutrophils adhere to erythrocytes in the presence of complement. Exp Cell Res (2005) 0.96
Alpha E beta 7 (CD103) expression identifies a highly active, tonsil-resident effector-memory CTL population. J Immunol (2005) 0.96
IgM are associated to Sp alpha (CD5 antigen-like). Electrophoresis (2002) 0.95
Immune adherence revisited: novel players in an old game. News Physiol Sci (2003) 0.95
Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J Immunol (2011) 0.94
Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option? Nephrol Dial Transplant (2009) 0.92
Ectosomes of polymorphonuclear neutrophils activate multiple signaling pathways in macrophages. Immunobiology (2012) 0.87
Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2. J Immunol (2002) 0.86
Erythrocyte-derived microvesicles amplify systemic inflammation by thrombin-dependent activation of complement. Arterioscler Thromb Vasc Biol (2013) 0.85
Proteomic analysis of a podocyte vesicle-enriched fraction from human normal and pathological urine samples. Proteomics Clin Appl (2008) 0.85
Human CD8+ T cells store CXCR1 in a distinct intracellular compartment and up-regulate it rapidly to the cell surface upon activation. Blood (2005) 0.84
High prevalence of infections and autoimmunity in patients with thymoma. Hum Immunol (2011) 0.84
No lupus nephritis in the absence of antiC1q autoantibodies? Nephrol Dial Transplant (2002) 0.84
Cyclooxygenase regulates cell surface expression of CXCR3/1-storing granules in human CD4+ T cells. J Immunol (2006) 0.83
Ectosomes as immunomodulators. Semin Immunopathol (2010) 0.82
The complement inhibitor, CRIT, undergoes clathrin-dependent endocytosis. Exp Cell Res (2005) 0.81
A peptide derived from the parasite receptor, complement C2 receptor inhibitor trispanning, suppresses immune complex-mediated inflammation in mice. J Immunol (2003) 0.80
Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis. Eur J Immunol (2014) 0.80
Case 40-2006: anemia and low HDL cholesterol. N Engl J Med (2007) 0.80
Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme. J Neurooncol (2014) 0.79
Epstein-Barr virus negativity among individuals older than 60 years is associated with HLA-C and HLA-Bw4 variants and tonsillectomy. J Virol (2013) 0.79
Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. Blood (2010) 0.79
Investigation of alloreactive NK cells in mixed lymphocyte reactions using paraformaldehyde-silenced target cells. J Immunol Methods (2007) 0.79
Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection. Hum Vaccin Immunother (2015) 0.79
Preserved antigen-specific immune response in patients with multiple sclerosis responding to IFNβ-therapy. PLoS One (2013) 0.78
Lymphocyte counts in patients with ANCA-associated vasculitis. Rheumatol Int (2008) 0.78
Intronic SH2D1A mutation with impaired SAP expression and agammaglobulinemia. Clin Immunol (2012) 0.77
Contrary to HIV, hepatitis C virus is not associated with erythrocytes in vivo. J Hepatol (2005) 0.77
17Beta-estradiol inhibits monocyte adhesion via down-regulation of Rac1 GTPase. J Mol Cell Cardiol (2005) 0.76
Homing frequency of human T cells inferred from peripheral blood depletion kinetics after sphingosine-1-phosphate receptor blockade. J Allergy Clin Immunol (2013) 0.76
Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT. Biochem J (2005) 0.76
A trial of complement inhibition in a patient with cryoglobulin-induced glomerulonephritis. Case Rep Nephrol Urol (2012) 0.76
CRIT peptide interacts with factor B and interferes with alternative pathway activation. Biochem Biophys Res Commun (2006) 0.76
Infection with human herpesvirus 8 and transplant-associated gammopathy. Transplantation (2004) 0.76
Serine Is an Essential Metabolite for Effector T Cell Expansion. Cell Metab (2017) 0.75
Neglected for too long? - CD8+ Tregs release NOX2-loaded vesicles to inhibit CD4+ T cells. J Clin Invest (2016) 0.75
Not your usual diarrhoea: severe colonic toxicity of mycophenolate due to intestinal CMV and EBV infection. BMJ Case Rep (2013) 0.75
Clinical proteomics: study of a cryogel. Proteomics (2006) 0.75
Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes. Transplantation (2015) 0.75
[Fever of unknown origin (FUO)]. Ther Umsch (2010) 0.75
Increased Epstein-Barr virus-specific antibody-levels in HIV-infected individuals developing primary central nervous system lymphoma. AIDS (2007) 0.75
Minimal T-cell requirements for triggering haemophagocytosis associated with Epstein-Barr virus-driven B-cell proliferation: a clinical case study. Ann Rheum Dis (2011) 0.75
A well-meant present from a friend. Nephrol Dial Transplant (2003) 0.75
Reticulocytes have a higher resistance to complement lysis than erythrocytes. Acta Haematol (2010) 0.75
A high-mobility, low-cost phenotype defines human effector-memory CD8+ T cells. Blood (2008) 0.75
Rituximab in a patient with Hyper-IgE syndrome. Arch Dermatol (2007) 0.75
Dominant Epstein-Barr virus-specific T-cell responses are maintained during moderate and intense immunosuppressive treatment. Ann Rheum Dis (2010) 0.75
[Immunodeficiency and infection]. Ther Umsch (2014) 0.75
Testing the "cytokine-ome" theory: a longitudinal pilot study in renal transplant recipients. Transplantation (2008) 0.75
A confusing patient's history: small or large vessel vasculitis? Rheumatol Int (2009) 0.75
[Combined-heterozygous deficiency of complement C7 in a patient with recurrent meningitis]. Med Klin (Munich) (2006) 0.75